Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.42 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.42 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.42 |
| ▸ | TRPV6 | Q9H1D0 | 3/20 | 0.42 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL10445518 | 1.00 | ALDH1A1 (0.45) | ALDH1A1RECQLORAI1ORAI2ORAI3 | |
| Fluorobenzene SCHEMBL10445356 | 0.91 | ENPP2 (0.40) | ALDH1A1RECQLORAI1ORAI2ORAI3 | |
| Chlorobenzene SCHEMBL10445337 | 0.91 | ORAI1 (0.46) | ALDH1A1RECQLORAI1ORAI2ORAI3 | |
| Toluene SCHEMBL9334989 | 0.91 | TSHR (0.39) | ALDH1A1RECQLORAI1ORAI2ORAI3 | |
| SCHEMBL2782096 | 0.89 | ALDH1A1 (0.34) | ALDH1A1RECQLENPP2TSHRMAPK1 | |
| SCHEMBL20491586 | 0.88 | MGLL (0.50) | ALDH1A1RECQLTSHRGAACA1 | |
| SCHEMBL1491911 | 0.88 | PCSK9 (0.41) | ALDH1A1RECQLORAI1ORAI2ORAI3 | |
| Trifluoromethylbenzene SCHEMBL10445339 | 0.86 | TRPV6 (0.50) | ALDH1A1RECQLORAI1ORAI2ORAI3 | |
| SCHEMBL292645 | 0.84 | MEN1 (0.40) | ALDH1A1RECQLENPP2CA4CA6 | |
| SCHEMBL363448 | 0.82 | TRPV6 (0.46) | ALDH1A1RECQLORAI1ORAI2ORAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260112694-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2026-04-23 | — | — | US | claimed |
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | Anthro Energy, Inc. (US) | 2026-03-26 | — | — | US | claimed |
| EP-4666334-A2 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| US-20250372706-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2025-12-04 | — | — | US | claimed |
| US-12482860-B2 | System and method for improved battery structural properties | Anthro Energy, Inc. (US) | 2025-11-25 | — | — | US | claimed |
| US-20250329799-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY | Anthro Energy, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| US-20250149631-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2025-05-08 | — | — | US | claimed |
| WO-2025091014-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2024173770-A2 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2024-08-22 | — | — | WO | claimed |
| US-20240283016-A1 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2024-08-22 | — | — | US | claimed |
| US-8937188-B2 | Process for the preparation of lasofoxifene tartrate | GLENMARK GENERICS LTD. (IN) | 2015-01-20 | — | — | US | claimed |
| EP-2424839-A2 | A PROCESS FOR THE PREPARATION OF LASOFOXIFENE TARTRATE | Glenmark Generics Limited (IN) | 2012-03-07 | — | — | EP | claimed |
| US-20120045648-A1 | PROCESS FOR THE PREPARATION OF LASOFOXIFENE TARTRATE | GLENMARK GENERRICS LTD (IN) | 2012-02-23 | — | — | US | claimed |
| WO-2010125578-A2 | A PROCESS FOR THE PREPARATION OF LASOFOXIFENE TARTRATE | GLENMARK GENERICS LIMITED (IN) | 2010-11-04 | — | — | WO | claimed |
| US-20260112694-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | Anthro Energy, Inc. (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4666334-A2 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20040224923-A1 | Antibiotics containing borinic acid complexes and methods of use | ANACOR PHARMACEUTICALS, INC. | 2004-11-11 | — | — | US | disclosed |
| WO-2004056322-A2 | ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHODS OF USE | ANACOR PHARMACEUTICALS, INC. (US) | 2004-07-08 | — | — | WO | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040224923-A1 | Antibiotics containing borinic acid complexes and methods of use | BPGM, BROX, TBCA | ALDH1A1 4215/4885RECQL 15/4885ORAI1 2189/4885 |
| US-20120045648-A1 | PROCESS FOR THE PREPARATION OF LASOFOXIFENE TARTRATE | CYP19A1, CYP51A1, CYP2F1 | ALDH1A1 1287/4885RECQL 4131/4885ORAI1 1353/4885 |
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | FTO, DCX, TET1 | ALDH1A1 2522/4885RECQL 670/4885ORAI1 956/4885 |
| US-20260112694-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | PARG, PUF60, PHOSPHO1 | ALDH1A1 3548/4885RECQL 1866/4885ORAI1 338/4885 |
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | ALDH1A1 198/4885RECQL 961/4885ORAI1 4577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.